These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16740688

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.
    Semela D, Piguet AC, Kolev M, Schmitter K, Hlushchuk R, Djonov V, Stoupis C, Dufour JF.
    J Hepatol; 2007 May; 46(5):840-8. PubMed ID: 17321636
    [Abstract] [Full Text] [Related]

  • 24. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N.
    Cancer Res; 2006 Feb 01; 66(3):1455-63. PubMed ID: 16452201
    [Abstract] [Full Text] [Related]

  • 25. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V.
    Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174
    [Abstract] [Full Text] [Related]

  • 26. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.
    Zhou Q, Liu LZ, Fu B, Hu X, Shi X, Fang J, Jiang BH.
    Carcinogenesis; 2007 Jan 15; 28(1):28-37. PubMed ID: 16774940
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
    Kong D, Okamura M, Yoshimi H, Yamori T.
    Eur J Cancer; 2009 Mar 04; 45(5):857-65. PubMed ID: 19144509
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Concurrent and sequential administration of chemotherapy and the Mammalian target of rapamycin inhibitor temsirolimus in human cancer cells and xenografts.
    Fung AS, Wu L, Tannock IF.
    Clin Cancer Res; 2009 Sep 01; 15(17):5389-95. PubMed ID: 19706800
    [Abstract] [Full Text] [Related]

  • 39. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H, Liu N.
    Pancreas; 2007 Mar 01; 34(2):242-7. PubMed ID: 17312464
    [Abstract] [Full Text] [Related]

  • 40. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
    Nizamutdinova IT, Lee GW, Lee JS, Cho MK, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC, Kim HJ.
    Carcinogenesis; 2008 Oct 01; 29(10):1885-92. PubMed ID: 18586687
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.